The role of ERBB2d16 played in promoting EMT has been reported in breast cancer, and in the prior studies, the number of mesenchymal cells was significantly increased in high ERBB2d16 tumor tissues compared with high ERBB2 breast tumor tissues (7). This evidence concerns the gene ERBB2 and breast carcinoma.